VistaGen Therapeutics to Participate in Baird’s 2021 Global Healthcare Conference
September 08 2021 - 8:00AM
VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company
committed to developing a new generation of medicines with the
potential to go beyond the current standard of care for anxiety,
depression, and other central nervous system (“CNS”) disorders,
today announced that management will participate in Baird’s 2021
Global Healthcare Conference, including a fireside chat with Shawn
Singh, Chief Executive Officer, on Tuesday, September 14 at 12:10
p.m. Pacific Time and one-on-one meetings throughout the two-day
conference.
A live webcast of VistaGen’s presentation will be accessible
through the News/Events page of the Investors section of the
Company’s website at www.VistaGen.com.
About VistaGenVistaGen Therapeutics is a
biopharmaceutical company committed to developing and
commercializing innovative medicines with the potential to go
beyond the current standard of care for anxiety, depression, and
other CNS disorders. Each of VistaGen's three drug candidates has a
differentiated potential mechanism of action, has been
well-tolerated in all clinical studies to date, and has therapeutic
potential in multiple CNS markets. For more information, please
visit www.VistaGen.com and connect with VistaGen
on Twitter, LinkedIn, and Facebook.
VistaGen Company Contacts
Media:Mark McPartlandPhone: (650) 577-3606Email:
IR@vistagen.com
Investors:Mark FlatherPhone: (650) 577-3617Email:
IR@vistagen.com
VistaGen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
VistaGen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From Apr 2023 to Apr 2024